32 results
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
3 Oct 22
Soleno Therapeutics Announces Initiation of Randomized Withdrawal Study of
9:00am
patients. Upon Institutional Review Board/Ethics approvals at their respective sites, patients who consent to participate in the randomized withdrawal
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
expectations. We anticipate initiating our U.K. sites shortly, which depends on the timing of local regulatory and ethics processes.”
Under the terms
424B3
4x4 kqt6vem1qvb3w6fo
12 Apr 19
Prospectus supplement
4:41pm
S-1/A
kkni81
1 Jul 14
IPO registration (amended)
12:00am